CATEGORIES

Patient Zone

LATEST

TRENDING

EDITORS CHOICE

First NASH Patient Dosed with CRV431 in Phase 2 ‘AMBITION’ Clinical Trial

The ‘AMBITION' trial, is designed to assess safety, tolerability, and pharmacokinetics of 75 mg CRV431, administered orally to F2 and F3 NASH patients

Why We Should Be Cautious With COVID-19 Medical Research

Thalidomide’s history is a grim reminder of what can go wrong when a drug comes to market without proper clinical trials and oversight.

Preparing for: Laparoscopic Supracervical Hysterectomy

This article will help you prepare for a Laparoscopic Supracervical Hysterectomy. Understand what is involved in the procedure and

We Get No Credit For Being Good Clinicians

I was honored to be on a panel of experts for a webinar on sepsis denials by payers, especially commercial insurance companies. I had previously written...